Edition:
United States

Biotechnology & Medical Research

Achaogen offers up to 5 mln shares in public offering

May 23 (Reuters) - Achaogen Inc :Achaogen announces proposed public offering of common stock.Achaogen inc- commenced an underwritten public offering of up to 5 million shares of its common stock.Achaogen - expects to use net proceeds from offering to fund its ongoing development and preparation for...

4:03pm EDT

Ascendis Pharma A/S Q1 loss per share eur 0.78

May 23 (Reuters) - Ascendis Pharma A/S :Ascendis pharma a/s reports first quarter 2017 financial results.Q1 loss per share eur 0.78.Ascendis pharma a/s qtrly revenue eur 372,000 versus eur 1.26 million.Ascendis pharma a/s - as of march 31, 2017, company had cash and cash equivalents of eur 157.6...

4:01pm EDT

Spring Bank Pharma provides positive mid-stage data on Hep B drug

May 23 (Reuters) - Spring Bank Pharmaceuticals Inc :Spring bank pharmaceuticals announces top-line results from the initial cohort of the phase 2a segment of the achieve trial, a global phase 2 clinical trial for chronic hepatitis b virus (hbv).Spring bank - sb 9200 shows favorable safety profile...

4:00pm EDT

G1 Therapeutics announces closing of initial public offering

May 23 (Reuters) - G1 Therapeutics Inc :G1 Therapeutics announces closing of initial public offering.

8:00am EDT

Restructuring & Reorganization

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.